Titan pharmaceuticals message board
WebTitan Pharmaceuticals ( NASDAQ:TTNP ) Third Quarter 2024 Results Key Financial Results Revenue: US$95.0k (down 64% from... Simply Wall St. Here's Why We're Watching Titan Pharmaceuticals'... WebTitan Pharmaceuticals Announces Board Expansion and Management Changes SOUTH SAN FRANCISCO, Calif., Aug. 16, 2024 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has expanded its Board of Directors (the "Board") from five (5) to eleven (11) and appointed six new directors …
Titan pharmaceuticals message board
Did you know?
WebTitan Pharmaceuticals, Inc. Message board - Online Community of active, educated investors researching and discussing Titan Pharmaceuticals, Inc. Stocks. Home Recent … WebTitan Pharmaceuticals, Inc. (TTNP) Stock Forum & Discussion - Yahoo Finance My Portfolio Market Data Industry News Currency Converter Canada markets open in 5 hours 59 minutes S&P/TSX 20,275.54...
WebTitan Pharmaceuticals, Inc. is a development-stage biotechnology company developing proprietary therapeutics using its clinically proven ProNeura ® long-term, continuous drug delivery technology. WebTitan Pharmaceuticals Receives Funding to Develop Combination HIV Therapeutic and Contraceptive Implant for Women in Developing Countries October 25, 2024 Titan …
WebPresident and Chief Operating Officer Dr. DeVarney has served as a Director of Titan’s Board of Directors since 2024 and in October 2024, she became Titan’s President and Chief Operating Officer. She previously served as Chief Scientific Officer and has been with the Company since 2007. WebTitan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, proNeura. Its …
WebJan 15, 2024 · Titan Pharmaceuticals, Inc. Jan 15, 2024, 09:15 ET. SOUTH SAN FRANCISCO, Calif., Jan. 15, 2024 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) today announced it has entered into a ...
WebSep 14, 2024 · Titan Pharmaceuticals, Inc. (NASDAQ: TTNP ), based in South San Francisco, CA, is a commercial stage company developing proprietary therapeutics with its ProNeura ® long-term, continuous drug... hb pencil shadesWebDec 15, 2024 · TTNP Stock Message Board for Investors. Titan Pharmaceuticals, Inc. Stock Price, News and Company Updates. Message Board Total Posts: 60 gold bond powder canadaWebApr 14, 2024 · Titan Pharmaceuticals' mailing address is 400 OYSTER POINT BLVD SUITE 505, SAN FRANCISCO CA, 94080. The official website for the company is … hbp financial servicesWebOct 23, 2024 · TTNP Titan Pharmaceuticals Inc Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PRO... hbp evercare star plus oonWebTitan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, ProNeura. Its lead product... hbp for coldsWebJul 11, 2024 · Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has received funding from the Bill & Melinda Gates Foundation to support the demonstration of its... gold bond powder cancer riskWebSOUTH SAN FRANCISCO, Calif., Dec. 21, 2024 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has commenced a process to explore and evaluate strategic alternatives to enhance shareholder value. Titan has engaged Maxim Group LLC as its exclusive financial advisor to assist in this process. hbp foreign child